Safety Study of INV-347 for Obesity
Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 91 (estimated)
- Sponsor
- Novo Nordisk A/S · Industry
This trial is looking for adults who have previously taken the drug INV-347. Participants will not receive the drug again; instead, the study will check the safety of INV-347 based on prior doses. The study will last until the 21st visit.
You may be able to join if
- I have given informed consent before any study-related activities.
- I am a male or female.
- I am 18 years or older.
- I have taken INV-347 in a previous study and have measurable levels of the drug in my blood.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe study looks at the safety and blood levels of the study drug INV-347 in participants who were previously dosed with INV-347 in study INV-CL-108. Participants will not get any study drug in this study as it looks into the safety of a drug previously dosed. The study will last until visit 21.
Loading trial locations…